Navigation Links
Application of Genomatix in silico methods reveals novel cancer associated genes

Genomatix Software GmbH, an in silico systems biology company with headquarter in Munich (Germany), released today that researcher in Dublin, Ireland and Boston, U.S.A. identified novel cancer associated genes, based on strategies and products developed and promoted by Genomatix. Experimental verification by siRNA knock-down and RT-PCR confirmed the in silico results.

"I am delighted that an ever increasing number of scientists proof the validity of our concepts and experience the value of our integrated approach. This excellent work, carried out by researchers at The Conway Institute of the University College, Dublin, The Mater Misericordiae University Hospital in Dublin and The Beth Israel Deaconess Medical Center in Boston demonstrates a straightforward strategy from computer analysis to experimental verification.", says Klaus May, Chief Business Officer at Genomatix. He continues:" Two years ago we introduced our own concepts of an annotation and biology driven microarray analysis pipeline, and were heavily contested in the beginning. Today it is so rewarding to our scientists and developers to see the impact of our own ideas and research to cutting edge science of today."


Source:Genomatix Software GmbH

Page: 1

Related biology news :

1. Genomatix, AAAS ink agreement
2. Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible?status
3. Genomatix technology facilitates de novo identification of new renal disease associated genes
4. MatBase -- A new transcription factor knowledge base released by Genomatix
5. Ophthalmologists implant five patients with artificial silicon retina microchip
6. Researchers get neurons and silicon talking
7. Nano machine switches between biological and silicon worlds
8. Antioxidant protects against lung damage in silicosis
9. Studies reveal methods viruses use to sidestep immune system
10. New methods of gene delivery using lasers
11. Shift of weather patterns necessitates rethinking of reforestation methods
Post Your Comments:

(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... ANGELES and HOLLISTON, Mass. ... Technology, Inc. (Nasdaq: HART ), a biotechnology company ... that CEO Jim McGorry will present at ... December 1, 2015 at 2:30 p.m. PT. The presentation ... below) for 30 days. Management will also be available ...
(Date:11/25/2015)... ... 25, 2015 , ... A long-standing partnership between the Academy ... been formalized with the signing of a Memorandum of Understanding. , AMA Executive ... Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA Headquarters ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
Breaking Biology Technology: